Tiefenbacher New Market Launch: generic launch Teriflunomide

New market launch: Tiefenbacher Pharmaceuticals successfully launches the generic version of Teriflunomide in more than 20 European countriesTiefenbacher Pharmaceuticals has successfully prepared a day one launch of the generic version of the Multiple Sclerosis (MS) medication Teriflunomide (reference brand name: Aubagio). This complex generic launch explicitly follows Tiefenbacher Group`s strategy to make high quality pharmaceuticals […]
Tiefenbacher Pharmaceuticals New Market Launch: Teriflunomide

NEW MARKET LAUNCH: TIEFENBACHER PHARMACEUTICALS SUCCESSFULLY LAUNCHES FIRST GENERIC VERSION OF THE MULTIPLE SCLEROSIS MEDICINE TERIFLUNOMIDE IN CANADAWe at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines better affordable and better available for patients around the world. That´s why we are happy to share that we have successfully prepared the launch of the generic version […]